Published in EMBO J on December 20, 1987
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proc Natl Acad Sci U S A (1988) 2.78
Atrial G protein-activated K+ channel: expression cloning and molecular properties. Proc Natl Acad Sci U S A (1993) 2.57
In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem J (1992) 2.14
Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc Natl Acad Sci U S A (1991) 2.00
Direct interaction of gbetagamma with a C-terminal gbetagamma-binding domain of the Ca2+ channel alpha1 subunit is responsible for channel inhibition by G protein-coupled receptors. Proc Natl Acad Sci U S A (1997) 1.96
Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci U S A (1990) 1.90
Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci U S A (1990) 1.89
Three cytoplasmic loops of rhodopsin interact with transducin. Proc Natl Acad Sci U S A (1989) 1.83
The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J (1989) 1.79
Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc Natl Acad Sci U S A (1998) 1.61
Unique regulatory properties of the type 2a Ca2+ channel beta subunit caused by palmitoylation. Proc Natl Acad Sci U S A (1998) 1.58
The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc Natl Acad Sci U S A (1990) 1.58
Distinct sequence elements control the specificity of G protein activation by muscarinic acetylcholine receptor subtypes. EMBO J (1990) 1.51
Enhancing functional production of G protein-coupled receptors in Pichia pastoris to levels required for structural studies via a single expression screen. Protein Sci (2006) 1.46
Molecular Architecture of G Protein-Coupled Receptors. Drug Dev Res (1996) 1.39
Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. Proc Natl Acad Sci U S A (1996) 1.39
Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes. Naunyn Schmiedebergs Arch Pharmacol (2013) 1.38
Muscarinic suppression of the M-current in the rat sympathetic ganglion is mediated by receptors of the M1-subtype. Br J Pharmacol (1989) 1.38
Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain. Mol Cell Biol (1994) 1.28
Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. EMBO J (1991) 1.25
Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci U S A (1991) 1.25
Activation of heteromeric G protein-gated inward rectifier K+ channels overexpressed by adenovirus gene transfer inhibits the excitability of hippocampal neurons. Proc Natl Acad Sci U S A (1997) 1.24
Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase. Proc Natl Acad Sci U S A (1988) 1.23
Kinetic and pharmacological properties of the M-current in rodent neuroblastoma x glioma hybrid cells. J Physiol (1992) 1.17
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles (2015) 1.11
Characterization and functional expression in mammalian cells of genomic and cDNA clones encoding a Drosophila muscarinic acetylcholine receptor. Proc Natl Acad Sci U S A (1989) 1.06
Simultaneous visualization of the translocation of protein kinase Calpha-green fluorescent protein hybrids and intracellular calcium concentrations. Biochem J (1999) 1.05
Muscarinic receptor is coupled with a cation channel through a GTP-binding protein in guinea-pig chromaffin cells. J Physiol (1991) 1.01
Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders. Mol Biosyst (2010) 1.01
Functional M3 muscarinic acetylcholine receptors in mammalian hearts. Br J Pharmacol (2004) 1.01
Differential occurrence of reluctant openings in G-protein-inhibited N- and P/Q-type calcium channels. J Gen Physiol (2000) 1.00
Pharmacology of the putative M4 muscarinic receptor mediating Ca-current inhibition in neuroblastoma x glioma hybrid (NG 108-15) cells. Br J Pharmacol (1991) 0.99
Evaluation of the Pichia pastoris expression system for the production of GPCRs for structural analysis. Microb Cell Fact (2011) 0.95
Functional and binding studies with muscarinic M2-subtype selective antagonists. Br J Pharmacol (1989) 0.94
Regulators of G protein signaling attenuate the G protein-mediated inhibition of N-type Ca channels. J Gen Physiol (1999) 0.93
On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors. Proc Natl Acad Sci U S A (1992) 0.92
Regulation of muscarinic acetylcholine receptor mRNA expression by activation of homologous and heterologous receptors. Proc Natl Acad Sci U S A (1992) 0.89
Muscarinic m1 receptor-stimulated adenylate cyclase activity in Chinese hamster ovary cells is mediated by Gs alpha and is not a consequence of phosphoinositidase C activation. Biochem J (1996) 0.88
Muscarinic acetylcholine receptor subtype expression in avian vestibular hair cells, nerve terminals and ganglion cells. Neuroscience (2007) 0.88
Expression of muscarinic receptor subtypes in tree shrew ocular tissues and their regulation during the development of myopia. Mol Vis (2009) 0.88
Tyrosine phosphorylation of paxillin and focal adhesion kinase by activation of muscarinic m3 receptors is dependent on integrin engagement by the extracellular matrix. Proc Natl Acad Sci U S A (1998) 0.88
Zebrafish M2 muscarinic acetylcholine receptor: cloning, pharmacological characterization, expression patterns and roles in embryonic bradycardia. Br J Pharmacol (2002) 0.88
Differential effects of allosteric M(1) muscarinic acetylcholine receptor agonists on receptor activation, arrestin 3 recruitment, and receptor downregulation. ACS Chem Neurosci (2010) 0.87
Molecular properties of muscarinic acetylcholine receptors. Proc Jpn Acad Ser B Phys Biol Sci (2013) 0.87
Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects. Mediators Inflamm (2012) 0.87
NO donors potentiate the beta-adrenergic stimulation of I(Ca,L) and the muscarinic activation of I(K,ACh) in rat cardiac myocytes. J Physiol (2002) 0.87
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems. PLoS One (2012) 0.86
Cloned M1 muscarinic receptors mediate both adenylate cyclase inhibition and phosphoinositide turnover. EMBO J (1988) 0.86
Release of endothelium-derived hyperpolarizing factor (EDHF) by M3 receptor stimulation in guinea-pig coronary artery. Br J Pharmacol (1995) 0.84
Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice. Br J Pharmacol (2009) 0.83
4-DAMP analogues reveal heterogeneity of M1 muscarinic receptors. Br J Pharmacol (1990) 0.83
Charged amino acids required for signal transduction by the m3 muscarinic acetylcholine receptor. EMBO J (1993) 0.82
High affinity acylating antagonists for muscarinic receptors. Life Sci (1992) 0.82
Receptor binding studies of soft anticholinergic agents. AAPS PharmSci (2001) 0.80
PC12 phaeochromocytoma cells contain an atypical muscarinic receptor binding site. Br J Pharmacol (1989) 0.80
Distinct muscarinic acetylcholine receptor subtypes mediate pre- and postsynaptic effects in rat neocortex. BMC Neurosci (2012) 0.80
Expression of muscarinic receptor subtypes in rat gastric smooth muscle: effect of M3 selective antagonist on gastric motility and emptying. Dig Dis Sci (1997) 0.79
The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling. Biochem J (1993) 0.79
Mutation screening of the muscarinic M(2) and M(3) receptor genes in normal and asthmatic subjects. Br J Pharmacol (2001) 0.78
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage. Front Cell Neurosci (2016) 0.78
Inositol trisphosphate mediates cloned muscarinic receptor-activated conductances in transfected mouse fibroblast A9 L cells. J Physiol (1990) 0.78
Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations. Br J Pharmacol (1991) 0.78
Cholinergic activity as a new target in diseases of the heart. Mol Med (2015) 0.78
Stereoselective inhibition of muscarinic receptor subtypes by the enantiomers of hexahydro-difenidol and acetylenic analogues. Br J Pharmacol (1990) 0.78
Site-directed mutagenesis of highly conserved amino acids in the first cytoplasmic loop of Drosophila Rh1 opsin blocks rhodopsin synthesis in the nascent state. EMBO J (1997) 0.77
Modulation of muscarinic-receptor expression in human embryonic lung fibroblasts by platelet-derived growth factor. Biochem J (1990) 0.77
Routes of delivery of muscarinic acetylcholine receptors to the plasma membrane in NG108-15 cells. Br J Pharmacol (1994) 0.77
Muscarinic acetylcholine receptor 1 gene polymorphisms associated with high myopia. Mol Vis (2009) 0.76
Changes in Membrane Cholesterol Differentially Influence Preferential and Non-preferential Signaling of the M1 and M3 Muscarinic Acetylcholine Receptors. Neurochem Res (2014) 0.75
Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria. Front Pharmacol (2016) 0.75
Viral infection induces dependence of neuronal M2 muscarinic receptors on cyclooxygenase in guinea pig lung. J Clin Invest (1996) 0.75
Zebrafish heart as a model to study the integrative autonomic control of pacemaker function. Am J Physiol Heart Circ Physiol (2016) 0.75
Enhancement of nitric oxide production by methylecgonidine in cultured neonatal rat cardiomyocytes. Br J Pharmacol (2002) 0.75
A G protein gamma subunit peptide stabilizes a novel muscarinic receptor state. Biochem Biophys Res Commun (2006) 0.75
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT. Front Pharmacol (2016) 0.75
A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol (1970) 155.96
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Rapid and sensitive protein similarity searches. Science (1985) 76.83
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16
A system for shotgun DNA sequencing. Nucleic Acids Res (1981) 52.99
Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem (1980) 28.03
The isolation and characterization of linked delta- and beta-globin genes from a cloned library of human DNA. Cell (1978) 22.88
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A (1979) 21.22
Establishing homologies in protein sequences. Methods Enzymol (1983) 15.70
Optimal sequence alignments. Proc Natl Acad Sci U S A (1983) 14.64
Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. Science (1986) 8.23
Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature (1986) 7.06
G proteins: a family of signal transducers. Annu Rev Cell Biol (1986) 5.38
Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (1986) 4.97
GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature (1985) 4.95
Isolation and structure of a rhodopsin gene from D. melanogaster. Cell (1985) 3.90
Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol (1986) 3.61
Primary structure and biochemical properties of an M2 muscarinic receptor. Science (1987) 3.16
Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core. Nature (1987) 2.73
The avian beta-adrenergic receptor: primary structure and membrane topology. Proc Natl Acad Sci U S A (1986) 2.45
Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry (1986) 2.14
Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett (1986) 2.03
Molecular properties of the muscarinic acetylcholine receptor. Annu Rev Neurosci (1987) 1.83
Acetylcholine hyperpolarizes central neurones by acting on an M2 muscarinic receptor. Nature (1986) 1.53
Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells. Proc Natl Acad Sci U S A (1975) 1.40
Muscarinic agonist binding and phospholipid turnover in brain. J Biol Chem (1983) 1.23
Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. J Pharmacol Exp Ther (1985) 1.18
The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells. Mol Pharmacol (1985) 1.15
The formation of inositol 1,2-cyclic 4,5-trisphosphate and inositol 1,2-cyclic 4-bisphosphate on stimulation of mouse pancreatic minilobules with carbamylcholine. J Biol Chem (1987) 1.10
Large scale preparation and characterization of membrane-bound and detergent-solubilized muscarinic acetylcholine receptor from pig atria. Prep Biochem (1984) 0.98
Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepine. Life Sci (1987) 0.96
Ligand interactions with membrane-bound porcine atrial muscarinic receptor(s). Biochemistry (1980) 0.91
A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini. J Pharmacol Exp Ther (1987) 0.91
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52
Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (1985) 12.08
Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol (1999) 11.77
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell (1987) 11.56
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell (1987) 11.15
Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature (1983) 10.64
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother (2000) 8.54
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (1997) 6.82
Comparative biochemical properties of normal and activated human ras p21 protein. Nature (1984) 6.50
A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36
Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem (1996) 6.22
Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature (1984) 6.21
Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature (1983) 5.90
Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun (1980) 5.68
Characterization of the human factor VIII gene. Nature (1984) 5.37
Comparison of phenotypic and genotypic techniques for identification of unusual aerobic pathogenic gram-negative bacilli. J Clin Microbiol (1998) 5.27
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science (1986) 5.25
Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family. Nature (1987) 5.12
Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity (1994) 5.06
Transferable R factors in enteric bacteria causing infection of the genitourinary tract. Lancet (1966) 5.01
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
R factors mediate resistance to mercury, nickel, and cobalt. Science (1967) 4.57
Expression of active human factor VIII from recombinant DNA clones. Nature (1984) 4.36
Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science (1987) 4.31
Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature (1983) 4.15
Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature (1983) 4.06
Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1984) 3.98
Marburg-virus disease in Kenya. Lancet (1982) 3.79
A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol Cell Biol (1988) 3.74
Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ (2003) 3.66
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity (2000) 3.45
Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics (1973) 3.33
Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31
Structure of human factor VIII. Nature (1984) 3.29
Primary structure and biochemical properties of an M2 muscarinic receptor. Science (1987) 3.16
Mode of action of novobiocin in Escherichia coli. J Bacteriol (1967) 3.09
Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis. J Pediatr (1978) 3.05
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci U S A (1990) 2.99
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (1998) 2.98
The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicol Appl Pharmacol (1969) 2.95
Identification of coryneform bacterial isolates by ribosomal DNA sequence analysis. J Clin Microbiol (2000) 2.87
Do pili play a role in pathogenicity of Haemophilus influenzae type B? Lancet (1982) 2.84
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol (2000) 2.78
Hemophilus influenzae type B susceptibility to 17 antibiotics. J Pediatr (1975) 2.74
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med (2001) 2.66
Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc Natl Acad Sci U S A (1983) 2.66
New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene (2010) 2.56
Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins. Annu Rev Biochem (1994) 2.53
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron (1991) 2.46
The avian beta-adrenergic receptor: primary structure and membrane topology. Proc Natl Acad Sci U S A (1986) 2.45
Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45
The costs of treating COPD in the United States. Chest (2001) 2.43
Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell (1999) 2.42
Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42
Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci (1992) 2.41
Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem (2001) 2.40
Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes. Cell (1987) 2.36
Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Hemophilus infleunzae type b. J Pediatr (1972) 2.33
Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem (1997) 2.33
Role of heat-labile toxigenic Escherichia coli and Reovirus-like agent in diarrhoea in Boston children. Lancet (1975) 2.31
A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol (1997) 2.31
Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol (2000) 2.29
Studies on the epidemiology of resistance (R) factors. I. Analysis of Klebsiella isolates in a general hospital. II. A prospective study of R factor transfer in the host. Ann Intern Med (1969) 2.28
Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci (2001) 2.28
Recovery of resistance (R) factors from a drug-free community. Lancet (1969) 2.26
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci U S A (1991) 2.24
Isolation and partial characterization of outer and inner membranes from encapsulated Haemophilus influenzae type b. J Bacteriol (1981) 2.21
Amino acid sequence of retinal transducin at the site ADP-ribosylated by cholera toxin. J Biol Chem (1984) 2.17
The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics (1989) 2.17
The reliability of quantitative electroencephalography as an indicator of cerebral ischemia. Anesth Analg (1995) 2.12
A new Conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron (1992) 2.10
Biological properties of a CD4 immunoadhesin. Nature (1990) 2.05
The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess (2006) 2.04
Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron (1991) 2.03
Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature (1988) 2.03
Comparison of protein A gene sequencing with pulsed-field gel electrophoresis and epidemiologic data for molecular typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2000) 2.03
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. Proc Natl Acad Sci U S A (1990) 1.99
A health week in rural general practice. Br Med J (1967) 1.99
Measuring appropriate use of acute beds. A systematic review of methods and results. Health Policy (2000) 1.97